(Q35102207)

6 August 2017

1 reference

title

Pharmacogenetics and the future of medical practice (English)

1 reference

6 August 2017

Klaus Lindpaintner

1

1 reference

6 August 2017

publication date

25 March 2003

1 reference

Journal of Molecular Medicine

6 August 2017

published in

1 reference

6 August 2017

volume

81

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

141-153

1 reference

Pharmacogenomics: translating functional genomics into rational therapeutics

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Genetic factors in aminoglycoside toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Proposed molecular and cellular mechanism for aminoglycoside ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Pharmacogenetics and future drug development and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

HIV-1 infection in a man homozygous for CCR5▵32

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-002-0416-5

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment

21 January 2018

1 reference

12 December 2020

HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group

1 reference

12 December 2020

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

12 December 2020

Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects

1 reference

12 December 2020

Not quite pharmacogenomics

1 reference

12 December 2020

10.1007/S00109-002-0416-5

Identifiers

DOI

1 reference

6 August 2017

1 reference